Eva-Lotta Allan

Eva-Lotta Allan, an independent director, has over 30 years of corporate, business development and operational experience from the biotechnology industry of private and public companies.

She is Chairman of C4X Discovery (C4XD.L) and a Non-Executive Director of Almirall (ALM.MC), Aleta Biotherapeutics, Targovax (TRVX) and she was previously a board director of Isconova and BIA.

During her five years as Immunocore’s Chief Business Officer she raised $320 million in a Series A round and established significant strategic partnerships with top pharmaceutical companies. Eva-Lotta was previously at Ablynx, where she served as Chief Business Officer for seven years taking the company public and structured several complex partnerships with pharmaceutical companies. Eva-Lotta has also held a number of roles in biotech companies including as Senior Director of Business Development and Site Operations (Europe) at Vertex Pharmaceuticals.

She has a degree in microbiology from Stockholm University and started her career at the Tumour biology department at the Karolinska Institute in Stockholm.